| Amber J Bartlett, MS, CCC-SLP | |
|
14130 23rd Ave N, Plymouth, MN 55447 | |
| (763) 383-7666 | |
| (763) 383-6013 |
| Full Name | Amber J Bartlett |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 14130 23rd Ave N, Plymouth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073248720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | 528438 (Minnesota) | Primary |
| Provider Name | Therapy Junction |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184958704 PECOS PAC ID: 0749508133 Enrollment ID: O20150415000898 |
News Archive
Close to half of adverse reactions to medicines among adult hospital and emergency patients could be avoided, shows a study from the Nordic School of Public Health NHV.
The rise of 'selfies' is having a huge impact on the facial plastic surgery industry according to a new study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll studies a select group of the organization's 2,700 members to uncover the latest trends in facial plastic surgery.
Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber J Bartlett, MS, CCC-SLP 14130 23rd Ave N, Plymouth, MN 55447 Ph: (763) 383-7666 | Amber J Bartlett, MS, CCC-SLP 14130 23rd Ave N, Plymouth, MN 55447 Ph: (763) 383-7666 |
News Archive
Close to half of adverse reactions to medicines among adult hospital and emergency patients could be avoided, shows a study from the Nordic School of Public Health NHV.
The rise of 'selfies' is having a huge impact on the facial plastic surgery industry according to a new study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll studies a select group of the organization's 2,700 members to uncover the latest trends in facial plastic surgery.
Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.
› Verified 1 days ago
Kristyne Bazinet, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Fernbrook Ln N Ste 138, Plymouth, MN 55447 Phone: 952-544-0349 | |
Kari Shoemaker, M.S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5855 Cheshire Parkway, Plymouth, MN 55446 Phone: 763-553-7600 | |
Megan Stumpf, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 15600 36th Ave N Ste 120, Plymouth, MN 55446 Phone: 763-595-0812 Fax: 763-595-0824 | |
Megan L Wroblewski, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3021 Harbor Ln N Ste 120, Plymouth, MN 55447 Phone: 763-551-3652 | |
Eric William Ernest, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14425 8th Ave N, Plymouth, MN 55447 Phone: 763-607-2091 Fax: 763-550-1633 | |
Anne R Lindgren, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Harbor Ln N, Suite 120, Plymouth, MN 55447 Phone: 763-551-3652 Fax: 763-551-1334 |